A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse
- 24 December 2001
- journal article
- review article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 63 (2), 89-98
- https://doi.org/10.1016/s0006-2952(01)00899-1
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonistsNeuropharmacology, 1998
- Epibatidine binding sites and activity in the spinal cordBrain Research, 1997
- Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental areaBrain Research, 1994
- Hyperalgesic and analgesic actions of morphine, U50-488, naltrexone, and (−)-lobeline in the rat brainstemPharmacology Biochemistry and Behavior, 1994
- Effects of lobeline, a nicotinic receptor agonist, on learning and memoryPharmacology Biochemistry and Behavior, 1993
- Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze testEuropean Journal of Pharmacology, 1993
- Relations between structure and nicotine‐like activity: X‐ray crystal structure analysis of (−)−cytisine and (−)−lobeline hydrochloride and a comparison with (−)−nicotine and other nicotine‐like compoundsBritish Journal of Pharmacology, 1989
- The comparative binding characteristics of nicotinic ligands and their pharmacologyPharmacology Biochemistry and Behavior, 1988
- Die Lobelia‐Alkaloide. IIEuropean Journal of Organic Chemistry, 1925
- Über die Alkaloide der Lobelia‐Pflanze. IBerichte der deutschen chemischen Gesellschaft (A and B Series), 1921